HowShorted

How shorted is ClearPoint Neuro, Inc.?

More shorted than 88% of the 2,877 ranked US companies

12.77%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
+0.31
5 reports (~10 weeks)
−2.36
Aggregate net short position time series for ClearPoint Neuro, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 202612.77%+0.31
15 Jul 202612.46%−2.04
30 Jun 202614.50%−2.08
15 Jun 202616.58%+0.60
29 May 202615.98%+0.85
15 May 202615.13%−1.53
30 Apr 202616.66%+0.97
15 Apr 202615.69%+0.74
31 Mar 202614.95%+0.49
13 Mar 202614.46%+2.76
27 Feb 202611.70%−0.52
13 Feb 202612.22%+0.55
30 Jan 202611.67%+0.47
15 Jan 202611.20%+0.49
31 Dec 202510.71%+0.43
15 Dec 202510.28%+1.29
28 Nov 20258.99%+0.85
14 Nov 20258.14%−0.67
31 Oct 20258.81%+0.43
15 Oct 20258.38%−0.67
30 Sep 20259.05%+0.72
15 Sep 20258.33%+0.08
29 Aug 20258.25%−0.72
15 Aug 20258.97%+0.54
31 Jul 20258.43%–

Frequently asked questions

How shorted is ClearPoint Neuro, Inc. right now?
12.77% of ClearPoint Neuro, Inc.'s (CLPT) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.